Why Guangzhou Pharmaceutical Group is optimistic about st Kangmei

Before the thunderstorm, Shengkangmei was one of the leading traditional Chinese medicines. Taking the pilot unit of information medical service platform in state administration of traditional chinese medicine as an opportunity, the company took the lead in laying out the whole Internet industry chain in the Chinese medicine industry, taking Chinese herbal pieces as the core, smart pharmacies and smart medicine cabinets as the starting point, taking "medicine gourd" as the service platform, centering on the system of "big health+big platform+big data+big service", taking advantage of the resources of the whole industry chain, actively exploring the intelligent manufacturing 4 and 0 in the Chinese medicine industry, and taking the lead in creating the "smart pharmacy" model. After reorganization and operation improvement, Kangmei Pharmaceutical's revenue increased in the first quarter, its loss decreased, and the company's situation improved. As a restructuring party, GPHL's acquisition of Kangmei Pharmaceutical will not only be for short-term stock speculation, but also have a longer-term strategic plan. The future development of Kangmei Pharmaceutical may go through the process from taking off the hat to revaluing the value, and it may take several years to realize the expectation of tenfold growth.